Content about Viral diseases

February 24, 2014

Hyland's recently added three line extensions to its portfolio of cough-cold products — both an adult and pediatric mucus expectorant and a nighttime option for toddlers.

LOS ANGELES — Hyland's recently added three line extensions to its portfolio of cough-cold products — both an adult and pediatric mucus expectorant and a nighttime option for toddlers. Mucus relief accounts for 14% of the cough-cold category, Hyland's reported, citing Nielsen data for the 52 weeks ended Jan. 18 across all channels. 

January 22, 2014

A new study from researchers at Ohio State University is reporting that older patients who receive written information on shingles were almost three times more likely to get vaccinated than those that didn’t receive a similar communication.

COLUMBUS, Ohio - A new study from researchers at Ohio State University is reporting that older patients who receive written information on shingles were almost three times more likely to get vaccinated than those that didn’t receive a similar communication. The study is also one of the first to show that using a patient’s electronic medical record coupled with pharmacist intervention markedly improves preventative care of shingles over the current standard.

December 18, 2013

Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced,

MARSHFIELD, Wis. — Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced Wednesday.

The study, published online in Clinical Infectious Diseases, also shows RSV is a common cause of respiratory illness in older adults and that the chance of infection increases with age.

December 13, 2013

According to published reports, Express Scripts may be looking to start a "price war" among the makers of the latest generation of drugs for hepatitis C — which promise much shorter treatment times than standard therapies, but also cost significantly more — in an effort to bring down prices.

The stakes are certainly high. According to Centers for Disease Control and Prevention, there are 3.2 million people in the United States chronically infected with hepatitis C and hence at risk for liver cancer, and the CDC recommends that anyone born between 1945 and 1965 get tested for the virus.

According to published reports, Express Scripts may be looking to start a "price war" among the makers of the latest generation of drugs for hepatitis C — which promise much shorter treatment times than standard therapies, but also cost significantly more — in an effort to bring down prices.

December 4, 2013

The program to vaccinate children against chickenpox introduced in 1996 does not seem to be behind an increase in recent years in the number of cases of shingles, according to a new study.

NEW YORK — The program to vaccinate children against chickenpox introduced in 1996 does not seem to be behind an increase in recent years in the number of cases of shingles, according to a new study.

October 9, 2013

Flu is at the top of the list of diseases older adults plan to ask about, according to results from a new Harris Interactive consumer awareness survey, sponsored by Merck. Most of the more than 600 surveyed adults age 60 years and older are at least somewhat likely to ask their healthcare professional about preventing the flu this year, and are significantly more likely to ask about this than prevention of such other potentially serious diseases as shingles.

WHITEHOUSE STATION, N.J. — Flu is at the top of the list of diseases older adults plan to ask about, according to results from a new Harris Interactive consumer awareness survey, sponsored by Merck. Most of the more than 600 surveyed adults age 60 years and older are at least somewhat likely to ask their healthcare professional about preventing the flu this year, and are significantly more likely to ask about this than prevention of such other potentially serious diseases as shingles.

June 18, 2013

Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

JERUSALEM — Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

Teva said it would acquire MicroDose Therapeutx for $40 million, plus up to $125 million in milestone payments and sales milestones and royalties from its lead product, MDT-637, an inhaled treatment for respiratory syncytial virus, or RSV.

April 4, 2013

The Food and Drug Administration approval this week of a generic genital herpes ointment made by Mylan could make a slight dent in the stock price of the company that makes the branded version.

MONTREAL — The Food and Drug Administration approval this week of a generic genital herpes ointment made by Mylan could make a slight dent in the stock price of the company that makes the branded version.

Canada-based Valeant Pharmaceuticals International said that while it expected Mylan to receive approval for a generic version of Zovirax (acyclovir) ointment, it did not include the approval in its original budget expectations and thus expected its earnings per share in fiscal year 2013 to be reduced by 30 to 40 cents.

April 3, 2013

The Food and Drug Administration has approved a new drug for genital herpes made by Mylan, the drug maker said.

PITTSBURGH — The Food and Drug Administration has approved a new drug for genital herpes made by Mylan, the drug maker said Wednesday.

Mylan announced the approval of acyclovir ointment in the 5% strength. The drug is a generic version of Valeant International's Zovirax, used to manage initial genital herpes and in limited, non-life-threatening mucocutaneous herpes simplex virus infections in patients with compromised immune systems.

February 19, 2013

Drug maker Gilead Sciences has recalled a single lot of an injected drug used to treat an opportunistic infection in AIDS patients due to the presence of foreign matter, the company said.

FOSTER CITY, Calif. — Drug maker Gilead Sciences has recalled a single lot of an injected drug used to treat an opportunistic infection in AIDS patients due to the presence of foreign matter in some vials, the company said.

Gilead announced the voluntary recall of lot B120217A of Vistide (cidofovir), an injected drug used to treat cytomegalovirus retinitis in patients with AIDS, due to particulate matter.

December 21, 2012

The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for reducing the severity of chickenpox symptoms, the agency said Friday.

The FDA announced the approval of Cangene Corp.'s Varizig (varicella zoster immune globulin [human]) for varicella zoster, the virus that causes chickenpox. The FDA said Varizig was the only FDA-approved immune globulin for the virus after exposure.

December 6, 2012

The consumer health division of GlaxoSmithKline has enlisted an Olympic gold medalist to educate the public about cold sores and promote its OTC cold sore treatment.

PARSIPPANY, N.J. — The consumer health division of GlaxoSmithKline has enlisted an Olympic gold medalist to educate the public about cold sores and promote its OTC cold sore treatment.

November 28, 2012

By the time Hurricane Sandy had finished sweeping up the East Coast, it left billions of dollars in damage and took dozens of lives.

ALTAMONTE SPRINGS, Fla. — By the time Hurricane Sandy had finished sweeping up the East Coast, it left billions of dollars in damage and took dozens of lives.

But it caused another dimension of hardship for some people: those living with chronic diseases.

July 9, 2012

Walgreens on Monday announced the expansion of its vaccination offerings in Florida to include shingles and pneumonia.

DEERFIELD, Ill. — Walgreens on Monday announced the expansion of its vaccination offerings in Florida to include shingles and pneumonia.

July 5, 2012

Parents are 52% less likely to develop a cold when exposed to a common cold virus than nonparents, researchers at Carnegie Mellon University have found.

PITTSBURGH — Parents are 52% less likely to develop a cold when exposed to a common cold virus than nonparents, researchers at Carnegie Mellon University have found.

June 21, 2012

A diagnostic test designed to detect the presence of dengue virus in people with symptoms of dengue fever or dengue hemorrhagic fever has been approved by the Food and Drug Administration, the Centers for Disease Control and Prevention announced Thursday.

ATLANTA — A diagnostic test designed to detect the presence of dengue virus in people with symptoms of dengue fever or dengue hemorrhagic fever has been approved by the Food and Drug Administration, the Centers for Disease Control and Prevention announced Thursday.

May 29, 2012

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

Watson announced Tuesday a settlement through one of its subsidiaries with Endo Pharmaceuticals and Teikoku Seiyaku Co. over its generic version of Lidoderm (lidocaine) topical patch. Lidoderm had sales of $1.2 billion during the 12-month period ended in March 2012, according to IMS Health.

April 23, 2012

It seems that many U.S. adults are unaware of what inoculations are government-recommended vaccinations, while more than half are not diligent about regular checkups with their primary care physician, according to a Walgreens survey.

DEERFIELD, Ill. — It seems that many U.S. adults are unaware of what inoculations are government-recommended vaccinations, while more than half are not diligent about regular checkups with their primary care physician, according to a Walgreens survey.

April 2, 2012

Two drug makers have finalized the design of a late-stage clinical trial for a vaccine against a common virus that can cause complications later in life.

SAN DIEGO — Two drug makers have finalized the design of a late-stage clinical trial for a vaccine against a common virus that can cause complications later in life.

Vical and Astellas Pharma announced Monday that they had finalized the general design of a phase-3 trial of TransVax, a vaccine against cytomegalovirus, or CMV, for transplant recipients.

October 21, 2011

This year’s jump in measles in the United States and Canada was costly and occurred among unvaccinated children and adults, suggested several studies being presented at the 49th Annual Meeting of the Infectious Diseases Society of America here Thursday.

BOSTON — This year’s jump in measles in the United States and Canada was costly and occurred among unvaccinated children and adults, suggested several studies being presented at the 49th Annual Meeting of the Infectious Diseases Society of America here Thursday.

October 10, 2011

Depomed has launched a new drug for treating shingles, the drug maker said Monday.

MENLO PARK, Calif. — Depomed has launched a new drug for treating shingles, the drug maker said Monday.

The company announced the launch of Gralise (gabapentin) tablets, a once-daily treatment for postherpetic neuralgia, the pain that follows healing of the rash associated with shingles.

Gralise is a proprietary formulation of gabapentin that uses patented polymer technology that enables gradual release of the drug. Depomed said it is not interchangeable with other branded or generic gabapentin-based drugs.

 

October 3, 2011

According to new research conducted by the University of Michigan, more than 1-out-of-10 parents of young children use an alternative vaccination schedule, a practice that may put children's health at risk.

ANN ARBOR, Mich. — According to new research conducted by the University of Michigan, more than 1-out-of-10 parents of young children use an alternative vaccination schedule, a practice that may put children's health at risk.

September 15, 2011

GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

LONDON — GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.

GSK announced that it would donate $1 million worth of Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) to the Pink Ribbon Red Ribbon Partnership over the next five years, as well as $50,000 to support the program operations. The partnership is an initiative led by Susan G. Komen for the Cure, UNAIDS, the President's Emergency Relief Plan for AIDS Relief and the George W. Bush Institute.

July 26, 2011

Chickenpox is the scourge of many a schoolchild and usually a convenient, if itchy and feverish, reason to stay home for several days, but it also has been fatal for many who catch it — until recently.

ELK GROVE VILLAGE, Ill. — Chickenpox is the scourge of many a schoolchild and usually a convenient, if itchy and feverish, reason to stay home for several days, but it also has been fatal for many who catch it — until recently.

According to a new study published in the journal Pediatrics, since a vaccine for varicella, the virus that causes chickenpox, became available in 1995, deaths from the virus have been virtually eliminated.

May 4, 2011

The Food and Drug Administration is cracking down on companies that it accuses of selling fake products for sexually transmitted diseases, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration is cracking down on companies that it accuses of selling fake products for sexually transmitted diseases, the agency said.

The FDA said at least 15 products — some sold as dietary supplements — that claim to treat, prevent or cure such STDs as herpes, Chlamydia, genital warts and HIV/AIDS, were being sold online and at some retail stores. Brands include MedaVir, which claims to treat herpes; Gene-Eden, which claims to treat a range of STDs, as well as flu and mononucleosis; and several others.